Literature DB >> 15038780

Phenotypic characterization of a human synovial sarcoma cell line, SW982, and its response to dexamethasone.

Taisuke Yamazaki1, Takashi Yokoyama, Hiromi Akatsu, Takashi Tukiyama, Takayoshi Tokiwa.   

Abstract

SW982 cells are characterized by expression of inflammatory cytokine and matrix metalloproteinase (MMP) genes and by their response to dexamethasone at different cell densities. They express genes encoding interleukin (IL)-1 beta; IL-6; transforming growth factor-beta; intercellular adhesion molecule-1; cycloxygenase (COX)-2; and MMPs, including MMP-1, MMP-2, MMP-13, and MT1-MMP; tissue inhibitor of metalloproteinase-2; and a disintegrin and metalloproteinase with thrombospondin motifs-4. Expression of all the genes examined was induced with 2 ng/ml IL-1 beta at low cell density. The cells, however, failed to express tumor necrosis factor-alpha, COX-1, and MMP-9, regardless of the presence of IL-1 beta. Dexamethasone significantly reduced IL-1 beta, IL-6, COX-2, and MMP-1 expression at high cell density. The results suggest that SW982 cells are a useful tool for studying the expression of inflammatory cytokine or MMP genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15038780     DOI: 10.1290/1543-706X(2003)039<0337:PCOAHS>2.0.CO;2

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  7 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Mechanisms of KE298, 2-acetylthiomethyl-3-(4-methylbenzoyl) propionic acid, to suppress abnormal synovial cell functions in patients with rheumatoid arthritis.

Authors:  T Sakane; N Suzuki; Y Hirose; K Miura; S Wakisaka; H Nagafuchi; M Ichino; T Tomita; H Hashimoto; T Ochi; S Mihara
Journal:  J Rheumatol       Date:  1997-11       Impact factor: 4.666

3.  Effects of mitogen-activated protein kinase inhibitors or phosphodiesterase inhibitors on interleukin-1-induced cytokines production in synovium-derived cells.

Authors:  F Tsuji; K Oki; T Senda; M Horiuchi; S Mita
Journal:  Immunol Lett       Date:  1999-06-01       Impact factor: 3.685

4.  In vivo effects of antirheumatic drugs on neutral collagenolytic proteases in human rheumatoid arthritis cartilage and synovium.

Authors:  J Martel-Pelletier; J M Cloutier; J P Pelletier
Journal:  J Rheumatol       Date:  1988-08       Impact factor: 4.666

5.  [Matrix metalloproteinase (MMP-9) in patients with rheumatoid arthritis].

Authors:  M Seki; M Uzuki; H Ohmoto; K Yoshino; S Maeda; S Kokubun; M Sakurai; T Sawai
Journal:  Ryumachi       Date:  1995-10

6.  Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors.

Authors:  R I Scheinman; A Gualberto; C M Jewell; J A Cidlowski; A S Baldwin
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

7.  Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis.

Authors:  N Auphan; J A DiDonato; C Rosette; A Helmberg; M Karin
Journal:  Science       Date:  1995-10-13       Impact factor: 47.728

  7 in total
  19 in total

1.  Pyrroloquinoline Quinone Decelerates Rheumatoid Arthritis Progression by Inhibiting Inflammatory Responses and Joint Destruction via Modulating NF-κB and MAPK Pathways.

Authors:  Zhongbing Liu; Chi Sun; Ran Tao; Xinbao Xu; Libin Xu; Hongbing Cheng; Youhua Wang; Dongmei Zhang
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

2.  Intercellular adhesion molecule-1 on synovial cells attenuated interleukin-6-induced inhibition of osteoclastogenesis induced by receptor activator for nuclear factor κB ligand.

Authors:  M Suzuki; M Hashizume; H Yoshida; M Shiina; M Mihara
Journal:  Clin Exp Immunol       Date:  2010-10-29       Impact factor: 4.330

Review 3.  Do you know the sex of your cells?

Authors:  Kalpit Shah; Charles E McCormack; Neil A Bradbury
Journal:  Am J Physiol Cell Physiol       Date:  2013-11-06       Impact factor: 4.249

4.  Potential role of fibroblast-like synoviocytes in joint damage induced by Brucella abortus infection through production and induction of matrix metalloproteinases.

Authors:  Romina Scian; Paula Barrionuevo; Guillermo H Giambartolomei; Emilio A De Simone; Silvia I Vanzulli; Carlos A Fossati; Pablo C Baldi; M Victoria Delpino
Journal:  Infect Immun       Date:  2011-07-05       Impact factor: 3.441

5.  In vitro model of hyaluronan synthase gene expression associated with lipopolysaccharide-induced inflammation in SW982 cell line.

Authors:  Nawarat Viriyakhasem; Siriprapa Khuajan; Prachya Kongtawelert; Ampai Panthong; Siriwan Ongchai; Vichai Reutrakul
Journal:  In Vitro Cell Dev Biol Anim       Date:  2014-06-17       Impact factor: 2.416

6.  KPNA2 Contributes to the Inflammatory Processes in Synovial Tissue of Patients with Rheumatoid Arthritis and SW982 Cells.

Authors:  Zhongbing Liu; Dongmei Zhang; Chi Sun; Ran Tao; Xinbao Xu; Libin Xu; Hongbing Cheng; Min Xiao; Youhua Wang
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

7.  Effect of dexamethasone on binding activity of transcription factors nuclear factor-kappaB and activator protein-1 in SW982 human synovial sarcoma cells.

Authors:  Taisuke Yamazaki; Takashi Tukiyama; Takayoshi Tokiwa
Journal:  In Vitro Cell Dev Biol Anim       Date:  2005 Mar-Apr       Impact factor: 2.416

8.  In vitro efficacy of polysaccharide-based nanoparticles containing disease-modifying antirheumatic drugs.

Authors:  Nan Zhang; Patricia R Wardwell; Rebecca A Bader
Journal:  Pharm Res       Date:  2014-03-05       Impact factor: 4.200

9.  Active compound of Zingiber cassumunar Roxb. down-regulates the expression of genes involved in joint erosion in a human synovial fibroblast cell line.

Authors:  Rujirek Chaiwongsa; Siriwan Ongchai; Phorani Boonsing; Prachya Kongtawelert; Ampai Panthong; Vichai Reutrakul
Journal:  Afr J Tradit Complement Altern Med       Date:  2012-10-01

10.  Pentraxin 3 is a marker of early joint inflammation in patients with juvenile idiopathic arthritis.

Authors:  Shai Padeh; Nahid Farzam; Gilad Chayen; Maya Gerstein; Yackov Berkun
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.